BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 20, 2000
View Archived Issues
Licensing opportunity from NIH: method of refolding recombinant endostatin
Read More
Licensing opportunity from NIH: neuropeptide for pain regulation, blood pressure control
Read More
Maxim looking to acquire Cytovia
Read More
MedImmune and Alkermes to develop inhalable form of MAb targeting RSV
Read More
Periodontix and PPL Therapeutics successfully complete feasibility study for transgenic P-113
Read More
Phase III results reported for Hemolink in cardiac bypass patients
Read More
Dura to launch second Allergan product
Read More
Celera Genomics and Geron to collaborate on human pluripotent stem cell genomics
Read More
Celgene and Novartis d-methylphenidate license agreement now in effect
Read More
Cel-Sci begins another collaboration with the NCI
Read More
Millennium and Lilly extend cardiovascular collaboration
Read More
Advanced Life Sciences to develop natural melanoma treatment
Read More
Lanepitant proves ineffective in reducing osteoarthritis pain
Read More
North American Vaccine shareholders approve Baxter acquisition
Read More
Oncolytics successfully completes initial toxicology studies of Reolysin
Read More
TKT files BLA for Fabry's disease treatment
Read More
Synsorb Biotech highlights achievements of two lead products during Q1
Read More
Data presented at Sitges workshop support further clinical development of DAPD
Read More
DMP-450: phase I/II results suggest promising antiviral efficacy, favorable toxicity profile
Read More
Pfizer/Warner-Lambert merger completed
Read More
Combinations containing SJ-3366 prove additive to synergistic against HIV isolates
Read More
Itavastatin favorably affects lipid profile without influencing glucose metabolism in NIDDM
Read More
Calcilytic NPS-2143 demonstrates bone anabolic effects in ovariectomized rats
Read More
Water-soluble MMP inhibitors and their use reported by Aventis
Read More
Merck and Banyu jointly develop new agents for obesity and its complications
Read More
Early development projects at Aventis include new erythromycin antibiotics
Read More
Combination therapy for heart failure
Read More
Selective alpha1A-adrenoceptor antagonists with an oxazolidinone structure
Read More
Inhibitors of intracellular signal transduction discovered by Ariad
Read More
New antimicrobial mutilin derivatives and their use described in patent issued to SB
Read More